Arcline Investment Management has acquired ChargePoint Technology, strengthening its global presence.
Growth-oriented private equity firm, Arcline Investment Management, has acquired sterile and contained pharmaceutical product transfer specialist, ChargePoint Technology, strengthening global presence.
According to a March 1, 2021 press release, the deal will involve the incorporation of ChargePoint Technology into Arcline’s broader specialty process technologies platform offering to support global customers. Through the acquisition, ChargePoint Technology will be able to further progress its development pipeline in enhanced sterile and contained process solutions. Additionally, it is expected that Arcline will be making several other acquisitions to support ChargePoint’s process technology platform and create a tailored biopharma processing offering.
“Partnering with Arcline is an incredible opportunity for us to further strengthen our commitment to delivering high-quality world class process solutions for our customers,” said Chris Eccles, CEO at ChargePoint Technology, in the press release. “Arcline share our energy, focus, and passion, a powerful synergy, which will further catalyze the innovation of our products and improve the support we offer customers across the globe. We look forward to working with the team at Arcline to build the process solution platforms of the future.”
Source: ChargePoint Technology
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.